{
 "context": "The following article called 'GSK joins China trade push as UK trumpets healthcare deals' was published on 2015-10-21. The body of the article is as follows:\n    \nTip : Use comma (,) to separate multiple quotes. Learn more... \nWed, Oct 21, 2015, 16:00 BST - UK Markets close in 30 mins. GSK joins China trade push as UK trumpets healthcare deals Reuters - UK Focus \u2013 9 minutes ago 52.78 +0.64 \nLONDON, Oct (HKSE: 3366-OL.HK - news ) 21 (Reuters) - GlaxoSmithKline (Other OTC: GLAXF - news ) 's chief executive is joining a new panel to promote trade between Britain and China, just over a year after the drugmaker was handed a record fine of nearly $500 million for bribing Chinese doctors. \nThe group has since been rebuilding its position in China. \nThe move came as Britain announced the signing of more than 2 billion pounds ($3.1 billion) of healthcare trade deals between Chinese and UK companies, universities and organisations during President Xi Jinping's visit to Britain. \nIn addition to GSK's Andrew Witty, the China-Britain Business Council said on Wednesday its new 30-strong advisory council would also include WPP CEO Martin Sorrell, Jaguar Land Rover boss Ralf Speth, Rio Tinto (LSE: RIO.L - news ) CEO Sam Walsh and HSBC Chairman Douglas Flint. ($1 = 0.6475 pounds) (Reporting by Ben Hirschler; Editing by Pravin Char)\n\n    The day before the article was published, the stock price of GlaxoSmithKline PLC was 29.19345474243164 and the day after the article was published, the stock price of GlaxoSmithKline PLC was ",
 "expected": "29.39204216003418",
 "date": "2015-10-21",
 "ticker": "GSK",
 "company": "GlaxoSmithKline PLC"
}